Charging Study Subjects. Neither Principal Investigator nor Institute will charge a Study Subject or third-party payer for Investigational Drug (see Section 8, Investigational Drug) or for any services reimbursed by CRO under this Agreement. 5.2
Appears in 1 contract
Sources: Clinical Study Agreement
Charging Study Subjects. Neither Principal Investigator nor Institute Institution will charge a Study Subject or third-party payer for Investigational Drug (see Section 8, Investigational Drug) or for any services reimbursed by CRO Pfizer under this Agreement. 5.2.
Appears in 1 contract
Sources: Clinical Study Agreement
Charging Study Subjects. Neither Principal Investigator nor Institute Institution will charge a Study Subject or third-party payer for Investigational Drug (see Section 8, Investigational Drug) or for any services reimbursed by CRO SPONSOR under this Agreement. 5.2.
Appears in 1 contract
Sources: Clinical Trial Agreement